Insider Transactions in Q3 2018 at Merck & Co., Inc. (MRK)
Insider Transaction List (Q3 2018)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 18
2018
|
Kenneth C Frazier Executive Chair |
SELL
Open market or private sale
|
Direct |
279,851
-28.8%
|
$19,589,570
$70.08 P/Share
|
|
Sep 18
2018
|
Kenneth C Frazier Executive Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
279,851
+22.36%
|
$10,074,636
$36.56 P/Share
|
|
Sep 17
2018
|
Adam H Schechter EVP & Pres-Global Human Health |
SELL
Open market or private sale
|
Indirect |
7,360
-11.73%
|
$515,200
$70.18 P/Share
|
|
Sep 17
2018
|
Adam H Schechter EVP & Pres-Global Human Health |
SELL
Open market or private sale
|
Direct |
100,000
-100.0%
|
$7,000,000
$70.18 P/Share
|
|
Sep 17
2018
|
Adam H Schechter EVP & Pres-Global Human Health |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+50.0%
|
$3,600,000
$36.56 P/Share
|
|
Aug 03
2018
|
Sanat Chattopadhyay Exe V-P & Pres. MMD |
SELL
Open market or private sale
|
Direct |
29,208
-36.2%
|
$1,898,520
$65.2 P/Share
|
|
Aug 03
2018
|
Sanat Chattopadhyay Exe V-P & Pres. MMD |
BUY
Exercise of conversion of derivative security
|
Direct |
29,208
+16.2%
|
$1,022,280
$35.49 P/Share
|
|
Aug 02
2018
|
Rita A Karachun Sr. VP Fince-Global Controller |
SELL
Open market or private sale
|
Direct |
5,000
-23.61%
|
$325,000
$65.01 P/Share
|
|
Jul 31
2018
|
Kenneth C Frazier Executive Chair |
SELL
Bona fide gift
|
Direct |
18,747
-2.64%
|
-
|
|
Jul 31
2018
|
Kenneth C Frazier Executive Chair |
SELL
Open market or private sale
|
Direct |
228,091
-24.3%
|
$14,825,915
$65.0 P/Share
|
|
Jul 31
2018
|
Kenneth C Frazier Executive Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
228,091
+19.55%
|
$7,527,003
$33.49 P/Share
|